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Objectives: To understand the role of Gem& species as a pathogen causing extra-abdominal infections in the 
Hospital General Universitario Gregorio Maranon. 
Materials and Methods: Between 1994 and 1998, one or more isolates of Gem&a sp. were found in 128 patients. The 
113 patients with isolates from nonsignificant specimens or representing intra-abdominal infections were excluded. 
The clinical records of the remaining 15 patients were reviewed as well as the more recent literature. 
Results: Mean age of patients was 41 years. The underlying conditions most frequently noted were intravenous drug 
users (n=6; 3 positive for human immunodeficiency virus), alcoholism (n=2), cardiovascular disease (n=2), chron- 
ic lung disease (n=2), diabetes (n=l), kidney transplant (n=l). The extra-abdominal infections were skin and soft 
tissue abscess (n=5), empyema (n=4), brain abscess (n=2), primary bacteremia (n=l), lung abscess (n=l), septic 
thrombophlebitis (n=l), complicated urinary tract infection (n=l). The infection was monomicrobial in six and 
polymicrobial in nine cases. Surgical drainage and betalactam antibiotics were used. The outcome was favorable in 
almost all cases. 
Conclusions: Gemella sp. should be included as a cause of localized soft-tissue abscesses, empyema, and bloodstream 
infection. No case of infective endocarditis was found. Although it is susceptible to several antibiotics, Gemella sp. 
requires a careful microbiologic diagnosis and a subtle clinical interpretation. 
Int J Infect Dis 2002; 6: 78-82 
Gemella morbillorum is a catalase-negative, gram- 
positive (variable), facultative anaerobic coccus, com- 
monly confused with oral or viridans type streptococci. 
The Gemella genus was officially proposed by Berger 
in 1961.l Gemella morbillorum had originally been 
identified as an anaerobic Peptostreptococcus sp and 
was transferred from the Streptococcus genus in 
1988.2 It is a normal component of the human upper 
respiratory, gastrointestinal and genital tract flora. Most 
isolates are probably misidentified in clinical micro- 
biology. 
The pathogenic ability of G. morbillorum is 
still under debate. It has been rarely associated with 
extra-abdominal human infections such as arthritis,3,4 
meningitis5 as well as bacteremia and endocarditis, not 
always associated with intravenous drug users 
(IVDU).6,7 The spectrum of extra-abdominal infections 
caused by these bacteria is not well known. This report 
presents 15 cases of Gemella species extra-abdominal 
infections observed in adults at the authors institution 
during the past 5 years and reviews the available litera- 
ture reported to date. 
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MATERIALS AND METHODS 
The Hospital General Universitario Gregorio Maranon 
is a large teaching institution, with approximately 1700 
beds, serving an urban and rural area of nearly 
650,000 inhabitants in the southeast area of Madrid, 
Spain. The hospital is also a referral center with all 
medical and surgical specialities, including heart, liver, 
and kidney transplantation units, and an active human 
immunodeficiency virus (HIV) unit. The estimated rate 
of IVDU (HIV infected and noninfected patients) 
attended at the center during the study period was 
2.8% (about 1400 admissions per year).8 
During the period of January 1994 to December 
1998,128 patients with one or more isolates of Gemella 
spp were retrospectively reviewed through clinical and 
microbiologic records. Infection by Gemella was 
defined as the presence of two or more of the following 
clinical signs: fever (>38”C), pain, warmth, tenderness, 
or the presence of exudative lesion on a suspected or 
radiologically confirmed area of infection, plus isolation 
of Gemella species from a well-related clinical specimen 
(blood, pleural fluid, surgical drainage). Cure was 
defined as a favorable clinical response with steriliz- 
ation of previous positive cultures (when clinically 
possible). Clinical isolates were identified following 
standard methods.9 
A MEDLINE search was conducted to identify all 
adult cases of extra-abdominal infections due to 
Gemella species published in English-language journals 
from 1966 to 1999 and fulfilling the case definition. 
Extra-abdominal infections attributable to Gemella species I Garcia-Lechuz Moya et al 79 
RESULTS 
Gemella spp were isolated in 128 patients during a 48 
month period (0.64 cases/1000 admissions). After 
reviewing the clinical records and cultures, the 263 
GemeZZa isolates from 128 patients were considered to 
be colonization in 55 patients and potential pathogen in 
73 patients. In the latter group, GemeZZa was isolated in 
58 patients with intra-abdominal infection as part of 
polymicrobial infection: 41 intra-abdominal abscesses 
and 17 peritoneal fluid. 
Fifteen cases with extra-abdominal infections 
attributable to Gemella spp were available for review, 
11.7% of the total number of patients (colonized or 
infected) with isolation of Gemella (Table 1). 
Epidemiologic data from the 15 patients with extra- 
abdominal infections with isolation of Gemella were as 
follows: average age, 41 years (range, 17-74 y); 11 males; 
4 females; most common underlying disease or associ- 
ated conditions: IVDU (n=6; 3 HIV-infected), alcohol 
abuse (n=2), cardiovascular disease (n=2), chronic lung 
disease (n=2), diabetes (n=l), kidney transplant (n=l). 
Some patients had more than one co-morbid condition, 
and a case without any of the cited conditions was 
found. 
The clinical presentation of the 15 cases were as 
follows: five skin and soft tissue infections, four 
empyema (one case with positive blood culture), two 
brain abscesses, one primary bacteremia, one lung 
abscess, one complicated urinary tract infection, and 
one septic thrombophlebitis and bacteremia. No cases 
of infective endocarditis were found. 
Gemella morbillorum was isolated in 11 patients 
and Gemella spp in four patients. Of them, nine cases 
were polymicrobial from skin and soft tissue abscesses 
and six cases were monomicrobial (three bacteremias 
and two empyemas). Gemella in pure culture, and 
together with viridans Streptococcus and Peptostrepto- 
coccus were iosolated from empyema and wound 
abscess in patient 12. In another four polymicrobial 
cases, cultures also yielded anaerobic microorganisms. 
Eight cases were treated with surgical drainage and 
antimicrobials. In only two cases, antibiotic treatment 
was specifically directed against Gemella. Beta-lactam 
antibiotics were used in 10 cases. The antimicrobial 
susceptibility pattern of Gemella was available in only 
seven cases (blood cultures and empyema). Overall, the 
strains were susceptible to penicillin. 
From the available data, 11 cases were noted to 
have had a favorable clinical outcome, and there was 
one death. In three cases, clinical outcome was unknown. 
DISCUSSION 
Gemella species are gram-positive coccal saprophytic 
microorganisms of the mucous membranes of humans. 
However, Gemellae are able to cause severe localized 
and generalized infections as opportunistic pathogens. 
They are uncommon causes of infectious endocarditis. 
Recently, endovascular Gemella infections affecting 
Figure 1. Abdominal and pelvic CT scan. Left psoas and right gluteal abscesses with isolation of Gemella spp and 5. spidermidis in 
an intravenous drug user, non-HIV patient (number 4). 
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children and adults have been more frequently 
reported in several countries.6J0-1z Generally, Gemellu 
endocarditis is associated with previous valvular 
damage or a poor dental state.‘jJ2J3 Gemella endo- 
carditis without preexistent valvular pathology and in 
nonaddicted patients has also been described.14J5 
Meningitis, septic arthritis, skin and soft tissue lesions, 
arteriovenous shunt infections, and bacteremia with or 
without endocarditis represent other clinical syndromes 
attributable to Gemella species.3-5J6-19 Empyema 
caused by Gemella has also been described.20-22 Four 
cases with isolation of Gemella from an empyema were 
found in this series. 
Clinically, patient age in this study differed from that 
reported previously for endocarditis and bacteremia. 
These patients were younger, and intravenous drug 
abuse was the principal risk factor for these infections. 
No endocarditis was found among the cases including 
the six drug abusers. Gemella become a significant 
pathogen in these patients, from colonized skin and 
soft tissue. Skin was the most commonly recognized 
portal of entry, although unknown origin was most fre- 
quent. 
Generally, the most common coexisting conditions 
encountered among adult patients (most of whom 
were elderly) with definitive or possible Gemella 
extra-abdominal infections were diabetes mellitus, 
chronic neurologic or renal disorders, vasculitis, chronic 
respiratory disease, alcoholism, and cardiovascular 
diseases.6J3’24 
Hematogenous seeding is the presumed source 
of Gemella endocarditis, although in some cases, 
bacteremia has never been demonstrated. It develops 
from bloodborne metastasis, direct implantation, or 
indirect local extension of microorganisms. Poor dental 
state or dental instrumentation are the predisposing 
factors. Some authors have tried to correlate endo- 
carditis with neoplastic diseases of the colon,14,25 and 
urogenital and puerperal infections with vaginal 
colonization by Gemella ~pp.~~ 
Diagnostically, two aspects are pertinent. Firstly, the 
microbiologic diagnosis requires at least a 48-hour 
culture (slow growth features) and additional tests or 
help from commercial kits to reach a species level 
identification (acid formation from carbohydrates, 
alkaline phosphatase).g Some difficulties were encoun- 
tered in the species identification so that Gemella 
sp was commonly reported in these cases. La Scola6 
recommends molecular identification for accuracy 
based on 16s rRNA gene analysis that helps to identify 
an increased number of pathogens. Secondly, some 
authors considered as definite criteria for the clinical 
diagnosis of Gemella infection (other than endocarditis), 
two or more plated cultures from blood samples or a 
100% Gemella culture growth from surgical aspirate or 
sterile space fluid specimen. Otherwise the infection is 
considered as possible. According to these criteria, 15 
cases of Gemella infection outside of the abdomen, 
were recorded in this study. Although a dual etiology is 
not included specifically in some of these criteria, 
ten cases with more than one significant isolation of 
Gemella and another clinically relevant bacteria were 
noted. Anaerobes from the oral flora and staphylococci 
(S. azueus and S. epidermidis) were the most frequent 
bacteria found in combination with Gemella in extra- 
abdominal infections. In all these cases, microbiologic 
isolation and careful clinical interpretation are 
essential. 
On the basis of in vitro susceptibility tests, Gemellu 
resembles those susceptibilities of the viridans strepto- 
cocci.6,9J7 Penicillin or ampicillin are the drugs of 
choice in the treatment of adult Gemella infection. 
However, patients allergic to penicillin, variable in vitro 
efficacy of erythromycin and tetracycline, and high 
resistance levels to trimethoprim, make vancomycin 
elegible. In our series, the main antibiotic used was 
cefotaxime, which was highly effective. In acute cases, 
the uniform sensitivity of Gemella to penicillin enables 
rational treatment to be initiated immediately. Good 
responses are described with intravenous penicillin plus 
gentamicin and ceftriaxone plus netilmicin in endo- 
carditis,5,27 although there is no difference in mortality 
rate compared with patients who received an amino- 
glycoside in addition to a beta-lactam agent (combina- 
tion therapy vs. beta-lactam therapy alone).9,28,2g 
Isolates of Gemella morbillorum tested were uniformly 
susceptible to beta-lactam antibiotics, erythromycin, 
tetracycline, gentamicin, and vancomycin (both by disk 
diffusion and broth microdilution methods). Some 
resistance patterns to erythromycin, clindamycin, tetra- 
cycline, aminoglycosides, and even vancomycin, and 
beta-lactam tolerance have been reported, making in 
vitro susceptibility mandatory for accurate treatment, 
especially in endocarditis. In central nervous system 
infections, a combination of two of these three: ampi- 
cillin, chloramphenicol, and cefotaxime, is considered a 
successful treatment. In nonendocardial infections, 
despite in vitro multiresistance patterns, the clinical out- 
come after beta-lactam monotherapy would be favor- 
able, particularly if proper surgical debridement is 
performed when it is indicated. 
Morbidity and mortality are significant in Gemella 
extra-intestinal infections. In this study of Gemella 
extra-intestinal infections other than endocarditis, only 
73% of cases were cured. The patients responded well 
to a short-course of antibiotic therapy, although in some 
cases, patients also required surgical intervention. 
In this brief experience, the four cases of Gemella 
empyema were not severe, and there was rapid response 
to treatment, without sequelae after drainage. 
Mortality rates from the reviewed reports of 
adult infections differ widely (8-30%). Nevertheless, 
the clinical consequences of Gemella endocarditis 
were often severe, with an overall mortality rate of 
20%.4,7J1J5J7 All adults with a first episode of Gemella 
bacteremia should have a careful examination to iden- 
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tify deep-seated infection, such as endocarditis or 
intra-abdominal or dental infection. Patients with 
endocarditis should receive a prolonged course of 
parenteral antibiotics; 4 to 6 weeks of therapy is 
warranted.7,23,25 
CONCLUSIONS 
Gemella morbillorum is an uncommon and often not 
well recognized microorganism whose clinical signifi- 
cance is debated. It represents an important component 
of the burden of the gastrointestinal flora and can be 
isolated from intra-abdominal infections. The authors 
found that a group of subjects within the study, particu- 
larly IVDU with skin and soft tissue infections, repre- 
sents a significant population affected by Gemella 
infections. Therefore, its isolation (both in mixed or 
pure culture) from extra-intestinal infections poses a 
clinical dilemma, and despite many remaining uncer- 
tainties, Gemella morbillorum should not be systematic- 
ally disregarded as a nonsignificant microorganism. 
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